Drug
Protamine sulfate
Protamine sulfate is a pharmaceutical drug with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
2(40%)
Results Posted
50%(1 trials)
Phase Distribution
Ph phase_4
3
60%
Ph not_applicable
2
40%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution5 total trials
Phase 4Post-market surveillance
3(60.0%)
N/ANon-phased studies
2(40.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
5
all time
Status Distribution
Active(2)
Completed(2)
Other(1)
Detailed Status
Recruiting2
Completed2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 43 (60.0%)
N/A2 (40.0%)
Trials by Status
recruiting240%
unknown120%
completed240%
Recent Activity
2 active trials
Showing 5 of 5
recruitingnot_applicable
Dose for Reversal of Heparin After Cardiopulmonary Bypass
NCT07477977
recruitingphase_4
Routine Versus Selective Protamine Administration to Reduce Bleeding Complications After Transcatheter Aortic Valve Implantation (POPular ACE TAVI)
NCT05774691
completedphase_4
Protamine Sulfate During Transcatheter Aortic Valve Implantation
NCT02974660
unknownnot_applicable
Systematic Evaluation of Protamine Doze in Cardiac Surgery
NCT03787641
completedphase_4
Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation
NCT03140631
Clinical Trials (5)
Showing 5 of 5 trials
NCT07477977Not Applicable
Dose for Reversal of Heparin After Cardiopulmonary Bypass
NCT05774691Phase 4
Routine Versus Selective Protamine Administration to Reduce Bleeding Complications After Transcatheter Aortic Valve Implantation (POPular ACE TAVI)
NCT02974660Phase 4
Protamine Sulfate During Transcatheter Aortic Valve Implantation
NCT03787641Not Applicable
Systematic Evaluation of Protamine Doze in Cardiac Surgery
NCT03140631Phase 4
Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5